MediPharm Labs Corp.
MEDIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $18 | $24 | $34 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $6 | $13 | $17 |
| Inventory | $9 | $10 | $8 | $11 |
| Other Curr. Assets | $5 | $3 | $3 | $5 |
| Total Curr. Assets | $33 | $37 | $47 | $66 |
| Property Plant & Equip (Net) | $19 | $25 | $18 | $26 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | -$18 | $1 |
| Total NC Assets | $21 | $27 | $18 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $54 | $64 | $65 | $92 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $4 | $3 |
| Short-Term Debt | $0 | $2 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $1 | $1 |
| Other Curr. Liab. | $5 | $7 | $5 | $6 |
| Total Curr. Liab. | $10 | $11 | $9 | $9 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $11 | $11 | $9 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $201 | $200 | $191 | $191 |
| Retained Earnings | -$187 | -$177 | -$164 | -$129 |
| AOCI | $29 | $29 | $28 | $22 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $43 | $53 | $56 | $83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $54 | $64 | $65 | $92 |
| Net Debt | -$11 | -$16 | -$24 | -$34 |